ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 191 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $601,374 | +702.5% | 270,889 | +868.7% | 0.04% | +950.0% |
| Q1 2024 | $74,941 | -15.9% | 27,963 | -6.1% | 0.00% | -33.3% |
| Q4 2023 | $89,075 | +169.9% | 29,791 | +5858.2% | 0.01% | +100.0% |
| Q4 2017 | $33,000 | +560.0% | 500 | +400.0% | 0.00% | – |
| Q3 2017 | $5,000 | -44.4% | 100 | -50.0% | 0.00% | -100.0% |
| Q2 2017 | $9,000 | 0.0% | 200 | -50.0% | 0.00% | 0.0% |
| Q3 2015 | $9,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 1,275,000 | $45,020,000 | 9.84% |
| Aviva Holdings Ltd. | 340,100 | $12,009,000 | 5.60% |
| Aisling Capital LLC | 837,125 | $29,559,000 | 5.38% |
| RA Capital Management | 704,701 | $24,883,000 | 3.05% |
| Rhenman & Partners Asset Management AB | 543,347 | $19,186,000 | 3.04% |
| BB BIOTECH AG | 1,408,542 | $49,736,000 | 1.63% |
| Antipodean Advisors LLC | 91,000 | $3,213,000 | 1.57% |
| Iguana Healthcare Management, LLC | 75,000 | $2,648,000 | 1.31% |
| Crawford Lake Capital Management, LLC | 93,551 | $3,303,000 | 1.31% |
| FT Options LLC | 22,834 | $806,000 | 1.06% |